Longitudinal neuroimaging analysis in mild-moderate Alzheimer’s disease patients treated with plasma exchange with 5% human albumin

Manuscript Number: 

17-0693R2

Author(s): 
Ángel Bittini, Mercè Boada, Mar Buendía, Joan Castell, Gemma Cuberas-Borros, Juan Adán Guzmán-De-Villoria, Isabel Hernández, Laura Núñez, Francesc Pujadas, Antonio Páez, Isabel Roca, Lourdes Rubio, Gustavo Torres, Mireia Torres, Lluís Tárraga

Disclosures

Ángel Bittini

  • Nothing to Disclose

Mercè Boada

  • Consulting Fees:
    Consultant for Araclon, Avid, Bayer, Elan, Grifols, Janssen/Pfizer, Lilly, Neuroptix, Nutricia, Roche, Sanofi and Servier
    Lecture Fees:
    Fees for lectures from Araclon, Esteve, Grifols, Janssen, Novartis, Nutricia, Piramal, Pfizer-Wyett, Roche and Servier
    Grants
    • Agency: 
      Funds for research from Araclon, Esteve, Grifols, Janssen, Novartis, Nutricia, Piramal, Pfizer-Wyett, Roche and Servier
      Dates: 
      2008-2017

Mar Buendía

  • Nothing to Disclose

Joan Castell

  • Nothing to Disclose

Gemma Cuberas-Borros

  • Nothing to Disclose

Juan Adán Guzmán-De-Villoria

  • Nothing to Disclose

Isabel Hernández

  • Nothing to Disclose

Laura Núñez

  • Sponsors:
    Clinical Project Manager

Antonio Páez

  • Sponsors:
    Medical & Technical Director - Clinical Trials

Francesc Pujadas

  • Nothing to Disclose

Isabel Roca

  • Nothing to Disclose

Lourdes Rubio

  • Nothing to Disclose

Lluís Tárraga

  • Nothing to Disclose

Mireia Torres

  • Sponsors:
    Clinical Research Leader

Gustavo Torres

  • Nothing to Disclose